Site Map
OPHG Home
Office of Public Health Genomics at Centers for Disease Control and Prevention
About Us
Expand Collapse Search by Date Modified
- About the Office of Public Health Genomics at Centers for Disease Control
- Welcome Message from Muin J. Khoury M.D., Ph.D. Director, OPHG
- Genomics 2010 At a Glance
- CDC Genomic Funding
- Annual Reports Archive
- 2008 Genomics Program Review
- 2007 Program Review
- 2007 10 Years of Public health Genomics at CDC (1997-2007)
- 2006 Genomics Program Review
- 2005 Genomics and Population Health
- 2004 Accomplishments and Priorities
- 2003 Genomics and Population Health
- 2002 Highlights
- 2001 Accomplishments
- 2000 Accompllishments
- 1999 Highlights
- 1997 Strategic Plan
- Public Health Genomics Staff
- Public Health Genomics Achievements (1997 - 2008)
- Contact Us
- Information for Visitors to the OPHG at CDC/OD Century Center
- Public Health Genomics Policies and Regulations
Events
Expand Collapse Search by Date Modified
- Upcoming Events in Genetics and Public Health
- Genetic conference materials online
- 2010 - 4th National Conference on Genomics and Public Health
- 2008 - 10 Years of Public Health Genomics
- 2006 - CoCHP National Health Promotion Conference
- 2005 - Genomics Day Presentations
- 2003 - Genomics and the Future of Public Health Symposium
- 2002 - Family History for Public Health and Preventive Medicine
- 2002 - Banking Newborn Blood Spots for Public Health
- 2001 - Genetic and Public Health Strategies to Primary Immunodeficiency Diseases
- 2000 - Genetics in Public Health- Connecting Research, Education, Practice and Community
- 1999 - 2nd National Conference - Menu Page
- 1998 - 1st National Conference on Genetics and Public Health
- Genetic conference materials online
Family History
Expand Collapse Search by Date Modified
- Family History Menu Page
Genetic Testing
Expand Collapse Search by Date Modified
- Genetic Testing Menu Page
- ACCE
- 2004 meeting summary
- ACCE Report
- ACCE Project
- Foundation for Blood Research in cooperative agreement with OPHG
- Breast Cancer
- Colon Cancer
- Colon Cancer, Analytic Validity: Draft Genetic Test Review[PDF 241KB]
- Cystic Fibrosis, Clinical Utility: Draft Genetic Test Review[PDF 305KB]
- Cystic Fibrosis, Clinical Validity: Draft Genetic Test Review[PDF 267KB]
- Cystic Fibrosis, Disorder Setting: Draft Genetic Test Review[PDF 321KB]
- Cystic Fibrosis, ELSI: Draft Genetic Test Review[PDF 240KB]
- Cystic Fibrosis, Glossary: Draft Genetic Test Review[PDF 343KB]
- Cystic Fibrosis, Introduction: Draft Genetic Test Review[PDF 152KB]
- Cystic Fibrosis
- Cystic Fibrosis, Analytic Validity: Draft Genetic Test Review[PDF 791KB]
- Cystic Fibrosis,Clinical Utility: Draft Genetic Test Review[PDF 347KB]
- Cystic Fibrosis, Clinical Validity: Draft Genetic Test Review[PDF 436KB]
- Cystic Fibrosis, Disorder Setting: Draft Genetic Test Review[PDF 55KB]
- Cystic Fibrosis, Glossary: Draft Genetic Test Review[PDF 239KB]
- Cystic Fibrosis, Introduction[PDF 226KB]
- Hemochromatosis
- Venous Thromboembolism
- Venous Thromboembolism, Analytic Validity: Draft Genetic Test Review[PDF 987KB]
- Venous Thromboembolism , Clinical Utility: Draft Genetic Test Review[PDF 284KB]
- Venous Thromboembolism, Clinical Validity: Draft Genetic Test Review[PDF 1.5MB]
- Venous Thromboembolism, Disorder Setting: Draft Genetic Test Review[PDF 348KB]
- Evaluation of Genomic Applications in Practice and Prevention (EGAPP™)
- CDC Director’s Innovation Award
- 2010 - Recommendations for Genetic Tests by EGAPP™ Working Group
- 2009 - Recommendations for Genetic Tests by EGAPP™ Working Group
- CDC Summaries of EGAPP™ Recommendation Statements
- EGAPP™ Working Group Methods Summary
- CYP450 Genotyping to Predict Response to SSRIs Used to Treat Non-psychotic Depression in Adults: EGAPP™ Recommendation
- Tumor Gene Expression Profiling To Predict Risk of Breast Cancer Recurrence: EGAPP™ Recommendation
- General Public: Can Tumor Gene Expression Profiling (GEP) Improve Outcomes in Patients With Breast Cancer?
- Health Professionals: More About the EGAPP™ Tumor Gene Expression Profiling To Predict Risk of Breast Cancer Recurrence Recommendation
- Health Professionals: Public Health Implications of Tumor Gene Expression Profiling to Predict Risk of Breast Cancer Recurrence
- Lynch Syndrome EGAPP Recommendation
- Should UGT1A1 Genotyping Be Used to Predict Response to Irinotecan Chemotherapy? EGAPP Recommendation
- General Public: Should UGT1A1 Genotyping be Used to Predict Response to Irinotecan Chemotherapy in Patients with Metastatic Colorectal Cancer?
- Health Professionals: More about the EGAPP™ UGT1A1 Genotyping Recommendation
- Health Professionals: Public Health Implications of UGT1A1 Genotyping and Use of Irinotecan Chemotherapy for Metastatic Colorectal Cancer
- EGAPP™ Steering Committee
- ACCE
HuGENet Home
Expand Collapse Search by Date Modified
- Human Genome Epidemiology Network
- HuGENet™ Collaborating Organizations
- HuGENet Frequently Asked Questions
- How to Participate in HuGENet™
- HuGE Case Studies
- Diabetes
- Factor V Leiden and Venous Thrombosis
- Fictional Scenario on Rheumatoid Arthritis
- NOD2 and Crohn Disease
- Obesity
- ODC - adenoma recurrence associated with aspirin use
- Parkinson Disease
- Parkinson Disease and Coffee Consumption
- HuGE Publications
- Khoury-Dorman Editorial - Human Genome Epidemiology Network
- HuGE Info on the Internet
- Commentary: Epidemiology and the Continuum from Genetic Research to Genetic Testing
- Reporting, Appraising, and Integrating Data On Genotype Prevalence and Gene-Disease Associations
- Genetic Test Evaluation: Information Needs of Clinicians, Policy-Makers and the Public
- Do We Need Genomic Research for the Prevention of Common Diseases with Environmental Causes?
- The Emergence of Networks in Human Genome Epidemiology: Challenges and Opportunities [The Changing Face Of Epidemiology]
- The path from genome-based research to population health: Development of an international public health genomics network
- The Human Genome Project Is Now Complete. How Do We Develop a Handle for the Pump?
- Turning the Pump Handle: Evolving Methods for Integrating the Evidence on Gene-Disease Association
- Human Genome Epidemiology (HuGE)- Translating Advances in Human Genetics into Population-based Data for Medicine and Public Health
- HuGE Reviews
- HuGE Workshops and Meetings
- HuGENet Workshop - January 16, 2009
- HuGENet Workshop - May 20, 2009
- HuGE Workshop - January 24-25, 2008
- HuGE Workshop - January 24-25, 2008 - Agenda
- HuGE Workshop - November 9-10, 2006
- STrengthening the REporting of Genetic Associations (STREGA) Workshop - June 15-16, 2006
- HuGE Workshop - October 6-7, 2005 - Intro
- HuGE Workshop - October 6-7, 2005 - Agenda
- Expert Panel - January 29-30, 2001
Implementation
Expand Collapse Search by Date Modified
- Implementation Menu Page
- State Implementation Activities Clickable Map
- Alabama
- Alaska
- Arizona
- Arkansas
- California
- Colorado
- Connecticut
- DC
- Delaware
- Florida
- Georgia
- Hawaii
- Idaho
- Illinois
- Indiana
- Iowa
- Kansas
- Kentucky
- Louisiana
- Maine
- Massachusetts
- Michigan
- Minnesota
- Mississippi
- Missouri
- Montanta
- Nebraska
- Nevada
- New Hampshire
- New Jersey
- New Mexico
- New York
- North Carolina
- North Dakota
- Ohio
- Oklahoma
- Oregon
- Pennsylvania
- Rode Island
- South Carolina
- South Dakota
- Tennesse
- Texas
- Utah
- Vermont
- Virginia
- Washington
- West Virginia
- Wisconsin
- Wyoming
- Tier 1 Genomic Applications Toolkit for Public Health Departments
- Tier 1 Genomic Applications and their Importance to Public Health
- State and Local Public Health Departments Can Play Key Roles in Addressing Tier 1 Genomic Applications
- How to Use This Toolkit
- New Update Log
- More Detailed Information on Key Tier 1 Applications - Lynch Syndrome
- Phase 1 LS Approaches
- Phase 2 LS Approaches
- Lynch Syndrome tools and educational materials
- LS Tier 1 tools and educational materials from states and other sources
- Selected LS Tier 1 publications
- More Detailed Information on Key Tier 1 Applications - Hereditary Breast and Ovarian Cancer (HBOC)
- Phase 1 HBOC Approaches
- Phase 2 HBOC Approaches
- CDC tools and information on HBOC Tier 1
- HBOC Tier 1 tools and educational materials from states and other sources
- Selected HBOC Tier 1-related journal publications
- More Detailed Information on Key Tier 1 Applications - Familial Hypercholesterolemia
- Additional Information on Phase 1 FH Approaches
- Phase 2 FH Approaches
- FH tools and educational materials
- FH Tier 1 tools and educational materials from states and other sources
- Selected FH Tier 1 related publications
- Tier 1 Implementation Videos, Other Tools, and Resources Available to Help
- State Implementation Activities Clickable Map
Pathogen Genomics
Expand Collapse Search by Date Modified
Population Research
Expand Collapse Search by Date Modified
- Population Health Menu Page
- 2008 CDC Seed Funding for Public Health Genomics Research
- 2006 CDC Seed Funding for Public Health Genomics Research
- 2005 Biobank Workshop
- Influenza
- Genome Variation Estimates
- Allele Genotype Tables
- Genetic Variants Available, by Gene
- Genotyping Methods
- Spotlight
- Frequencies
- ABCB1 Allele and Genotype Frequencies
- ACE Allele and Genotype Frequencies
- ADH1B Allele and Genotype Frequencies
- ADH1C Allele and Genotype Frequencies
- ADRB1 Allele and Genotype Frequencies
- ADRB2 Allele and Genotype Frequencies
- ADRB3 Allele and Genotype Frequencies
- ALAD Allele and Genotype Frequencies
- CAPN10 Allele and Genotype Frequencies
- CAT Allele and Genotype Frequencies
- CBS Allele and Genotype Frequencies
- CCL5 Allele and Genotype Frequencies
- CCR2 Allele and Genotype Frequencies
- CXCL12 Allele and Genotype Frequencies
- CYP1A1 Allele and Genotype Frequencies
- CYP1A2 Allele and Genotype Frequencies
- CYP1B1 Allele and Genotype Frequencies
- CYP2A6 Allele and Genotype Frequencies
- CYP2C19 Allele and Genotype Frequencies
- CYP2C9 Allele and Genotype Frequencies
- CYP2E1 Allele and Genotype Frequencies
- CYP3A4 Allele and Genotype Frequencies
- F2 Allele and Genotype Frequencies
- F5 Allele and Genotype Frequencies
- FAM82A Allele and Genotype Frequencies
- FCGR2A Allele and Genotype Frequencies
- FGB Allele and Genotype Frequencies
- IL10 Allele and Genotype Frequencies
- IL1B Allele and Genotype Frequencies
- IL4 Allele and Genotype Frequencies
- IL4R Allele and Genotype Frequencies
- ITGA2 Allele and Genotype Frequencies
- ITGB3 Allele and Genotype Frequencies
- MBL2 Allele and Genotype Frequencies
- MTHFR Allele and Genotype Frequencies
- MTRR Allele and Genotype Frequencies
- NAT2 Allele and Genotype Frequencies
- NOS2A Allele and Genotype Frequencies
- NOS3 Allele and Genotype Frequencies
- NQO1 Allele and Genotype Frequencies
- OGG1 Allele and Genotype Frequencies
- PON1 Allele and Genotype Frequencies
- PPARG Allele and Genotype Frequencies
- SERPINE1 Allele and Genotype Frequencies
- TGFB1 Allele and Genotype Frequencies
- TLR4 Allele and Genotype Frequencies
- TNF Allele and Genotype Frequencies
- VDR Allele and Genotype Frequencies
- XRCC1 Allele and Genotype Frequencies
- NHANES
Public
Expand Collapse Search by Date Modified
Resources Links
Expand Collapse Search by Date Modified
- Resource Links for Office of Public Health Genomics
- A - B - C - D - E - F - G - H - I - J - N - P - R - S
- Books
- Human Genome Epidemiology (2nd ed.): Building the evidence for using genetic information to improve health and prevent disease (2010)
- Part 1, Chapter 1 - Human genome epidemiology: The road map revisited
- Part 1, Chapter 4 - Navigating the evolving knowledge of human genetic variation in health and disease
- Part 2, Chapter 7 - The emergence of networks in human genome epidemiology: Challenges and opportunities
- Part 2, Chapter 10 - STrengthening the REporting of Genetic Association Studies (STREGA)—An extension of the STROBE statement
- Part 2, Chapter 12 - Genome-wide association studies, field synopses, and the development of the knowledge base on genetic variation and human disease
- Part 3, Chapter 13 - Colorectal cancer
- Part 4, Chapter 22 - Evaluation of predictive genetic tests for common diseases: Bridging epidemiological, clinical, and public health measures
- Part 4, Chapter 23 - The Evaluation of Genomic Applications in Practice and Prevention (EGAPP™) initiative: Methods of the EGAPP™ working group
- Part 4, Chapter 26 - Assessing the evidence for clinical utility in newborn screening
- Part 4, Chapter 29 - The use of family history in public health practice: the epidemiologic view
- Human Genome Epidemiology: A Scientific Foundation for Using Genetic Information to Improve Health and Prevent Disease (2004)
- Human Genome Epidemiology: Preface
- Contibutors
- Chapter 1: Scope and Strategies
- Chapter 4: Ethical, Legal, and Social Issues in the Design and Conduct of Human Genome Epidemiologic Studies
- Chapter 5: Methods for Assessing Genotypes in Human Genome Epidemiology Studies
- Chapter 7: Facing the Challenge of Complex Genotypes and Gene-environment Interaction: the basic epidemiologic units in case-control and case-only designs
- Chapter 9: Applications of Human Genome Epidemiology to Environmental Health
- Chapter 10: Reporting and Review of Human Genome Epidemiology Studies
- Chapter 11: Epidemiologic Approach to Genetic Tests: Population-Based Data for Preventive Medicine
- Chapter 22: Immunogenetic Factors in Chronic Beryllium Disease
- Chapter 23: Fragile X Syndrome: Application of Gene Identification to Clinical Diagnosis and Population Screening
- Chapter 24: From Epidemiology to Clinical Practice: The Connexin Connection
- Chapter 28: Hereditary Hemochromatosis
- Chapter 29: Using Human Genome Epidemiology Information to Improve Health
- AJHG Book Review - Genetics and Public Health in the 21st Century (2002)
- Integrating Genomics into Public Health Policy and Practice (2002)
- AJHG Book Review- Genetics and Public Health in the 21st Century (2001)
- Genetics and Public Health in the 21st Century- Using Genetic Information to Improve Health and Prevent Disease (2000)
- Part 1 - Genetics and Public Health- An Overview; Chapter 1 - Genetics & Public Health- A Framework for the Integration of Human Genetics into Public Health Practice
- Part 2 - Public Health Assessment; Chapter 7 - Surveillance for Birth Defects & Genetic Diseases
- Part 2, Chapter 8 - Surveillance for Hemophilia and Inherited Hematologic Disorders
- Part 2; Chapter 9 - Public Health Assessment of Genetic Predisposition to Cancer
- Part 2; Chapter 10 - Public Health Assessment of Genetic Susceptibility to Infectious Diseases- Malaria, TB and HIV
- Part 2; Chapter 11 - Public Health Assessment of Genetic Information in the Occupational Setting
- Part 3 - Evaluation of Genetic Testing; Chapter 13 - Newborn Screening Quality Assurance
- Part 4 - Developing, Implementing, and Evaluating Population Interventions; Chapter 18 - Genetics and Prevention Effectiveness
- Part 4, Chap. 22 Newborn Screening for Sickle Cell Disease- Public Health Impact and Evaluation
- Part 4, Chap. 23 Public Health Strategies to Prevent the Complications of Hemochromatosis
- Part 5- Genetics and Public Health- Ethical, Legal, and Social Issues - Chap. 27 Public Health Surveillance of Genetic Information- Ethical and Legal
- Part 6- Communication, Education, and Information Dissemination - Chap. 31 Using the Internet to Disseminate Genetics Information for Public Health
- Genetic Epidemiology (1997)
- Epidemiology (1997)
- Human Genome Epidemiology (2nd ed.): Building the evidence for using genetic information to improve health and prevent disease (2010)
- Data and Statistics
- Educational materials
- Genetic Diseases
- Scientific Articles
- Software on this site
- CDC Genomic Podcasts/Videos
Spanish
Expand Collapse Search by Date Modified
- Bienvenidos a la Oficina de Genómica en Salud Pública
Training & Education
Expand Collapse Search by Date Modified
- Training Menu Page
- Genomics for Public Health Practitioners
- menu
- slide 1 - Title Page
- slide 2- Welcome
- slide 3 - Agenda
- slide 4 - Genetics vs. Genomics
- slide 5 - The Human Genome Project
- slide 6 - Definitions
- slide 7 - Applications
- slide 8 - Applications
- slide 9 - Public helath Genomics
- slide 10 - What is Hype?
- slide 11 - What is Reality for Public Health?
- slide 12 - Top 10 Causes of Death in the U.S.
- slide 13 - Gene-Environment Spectrum of Disease Causation
- slide 14 - Genetic Susceptibililty does not equal Health Destiny
- slide 15 - Potential Interventions
- slide 16 - Potential Interventions
- slide 17 - Potential Interventions
- slide 18 - We Should Wait?
- slide 19 - What we should do now
- slide 20 - What we should do now
- slide 21 - Identifying challenges
- slide 22 - Genomics in Action
- slide 23 - Family History
- slide 24 - Pedigrees
- slide 25 - Pedigrees
- slide 26 - Health Family Tree
- slide 27 - Health Family Tree Project
- slide 28 - Health Family Tree Project
- slide 29 - Health Family Tree Project
- slide 30 - Health Family Tree Project
- slide 31 - CDC Family History Public Health Initiative
- slide 32 - Conclusions
- slide 33 - How Can We Learn More?
- slide 34 - How Can We Learn More?
- slide 35 - How Can We Learn More?
- slide 36 - Thank You
- Transcript of Presentation
- menu
- Genomics for Public Health Practitioners
Translation
Expand Collapse Search by Date Modified
- Genomics Translation
- Genomic Competencies for the Public Health Workforce
- Frequently Asked Questions About Competencies for Genetics in Public Health
- Taxonomy of Educational Objectives- Affective Domain
- Genomic Competencies for the Public Health Workforce Background
- Taxonomy of Educational Objectives- Cognitive Domain
- Notes on Competency Development
- Public Health in America: Integrating Genetics
- Beyond Genomic Competencies 2001
- History and background for Genetics and Public Health
- Genomic Competencies for the Public Health Workforce Introduction
- Genomic Competencies for the Public Health Workforce Other Links
- Genomic Competencies for the Public Health Workforce Process
- Genomic Competencies for the Public Health Workforce Genomic Project Description
- Taxonomy of Educational Objectives- Psychomotor Domain
- Competencies for the Public Health Workforce- Integrating Genetics
- Taxonomy of Educational Objectives
- Team leaders and members
- Genomics Translation Projects Key Achievements Year 1
- Centers for Genomics
- Genomics Translation Projects Funded by CDC
- Prevention and Translation Research Initiative
- GAPPNet™
- Genetics for Early Disease Detection and Intervention
- State Genomics Programs
- Genomic Competencies for the Public Health Workforce
Weekly Update
Contact Us:
-
Centers for Disease Control and Prevention1600 Clifton Rd.
Atlanta, GA 30333 USA800-CDC-INFO (800-232-4636) - Additional information for Public Health Genomics is available on our contact page.